Vinay Prasad Md Mph
@vprasadmdmph·195K subscribers·579 videos
3.03 The National Lung Matrix Trial & the Major Flaw of the SPRINT Trial with Dr. Mark Friedberg
Posted
July 18, 2020
Views
622
Likes
11
Engagement
1.77%
July 18, 2020
622
11
1.77%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:09:29Now PlayingThis week we discuss two major papers: The first was just recently released in Nature and it's titled "The National Lung Matrix Trial of personalized therapy in lung cancer". The second is a few years old, but exemplifies the importance of trial design. We discuss the second paper, titled "A Randomized Trial of Intensive versus Standard Blood-Pressure Control" and published in the New England Journal of Medicine with Dr. Mark Friedberg, a health policies and performance measurement researcher.
National Lung Matrix Trial: doi.org/10.1038/s41586-020-2481-8
SPRINT: doi.org/10.1056/NEJMoa1511939
Back us on Patreon! www.patreon.com/plenarysession
Vinay Prasad
HemeOnc Doctor & Associate Professor
Host of Plenary Session Podcast
Twitter @vprasadmdmph
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
